secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001104659-25-090963
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte (HUMA) amends revenue interest purchase agreement; $50M repayment, discounted call option
--------------------------------------------------------------------------------

- Company to make $50.0M repayment under Purchase Agreement from restricted cash.
- Obligation to maintain $50.0M restricted cash removed; if not repaid by Dec 31, 2025, $12.5M required.
- Call option at discounted repurchase price of $95.5M if exercised on or before Dec 31, 2025; up to $7.5M may be paid in stock.
- Amendment executed with TPC Investments III LP and TPC Investment Solutions LP, agented by Hook SA LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925090963/0001104659-25-090963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925090963/tm2526406d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-090963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer